Hosnieh F.
About Hosnieh F.
Hosnieh F. is the Director and Disease Area Head of Innovative Medicine UK&I at Bristol Myers Squibb, with extensive experience in medical affairs and pharmaceutical medicine.
Current Role at Bristol Myers Squibb
Hosnieh F. is the Director, Disease Area Head, Innovative Medicine UK&I at Bristol Myers Squibb. In this role since November 2021, she leads various innovative medicine projects aimed at advancing treatment options. Her extensive experience in medical affairs and governance positions her as a pivotal leader in the company's innovation strategies.
Professional Experience at Almirall
From 2016 to 2019, Hosnieh F. was an integral part of Almirall's medical team. Initially serving as a Senior Medical Advisor from 2016 to 2017, she later became the Head of Medical Affairs from 2018 to 2019 in Uxbridge, Greater London. During her tenure, she was responsible for overseeing medical strategies and ensuring the execution of medical affairs operations.
Past Role at Retroscreen Virology
Hosnieh F. contributed significantly to Retroscreen Virology from 2012 to 2015. She began as a Physician in Pharmaceutical Medicine, then served as a Principal Investigator in 2013, and subsequently as an Associate Medical Director (AMD) from 2014 to 2015 in London, United Kingdom. Her roles focused on medical research and the advancement of clinical studies.
Educational Background
Hosnieh F. holds diverse qualifications from various prestigious institutions. She earned a Doctor of Medicine (M.D.) from the University of Tehran and an MSc from the University of Sheffield. Additionally, she completed an Executive MBA at Bayes Business School and holds multiple qualifications in pharmaceutical medicine, including a Diploma and Certificate of Completion of Specialist Training from the Faculty of Pharmaceutical Medicine.
Professional Involvement at Faculty of Pharmaceutical Medicine
Currently, Hosnieh F. is a Fellow at the Faculty of Pharmaceutical Medicine. This role highlights her ongoing contributions and dedication to the field of pharmaceutical medicine. Her fellowship underscores her expertise and commitment to advancing medical knowledge and practices.